Delivery Order SPE2DB20D3101-SPE2DB23FRHF7

Award Date 4/6/23
Potential Completion Date 4/7/23
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has an ultimate completion date of April 24, 2025 and a ceiling value of $2,687.32. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $13,395.36 and is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through October 2024. AmerisourceBergen holds a larger $999,999,999 IDC with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $17,320.52 and an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the provision of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $1,340.70 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $1,383.90 and is a Firm Fixed Price contract. The ultimate completion date is July 24, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,870.18 firm-fixed-price delivery order is for 4566248727 BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.13, is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,742.61, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. This award is not associated with a set-aside designation, indicating open...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a ceiling value of $8,555.39 and a performance period through April 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.18, is for the delivery of BRILINTA 60 MG TABLET 60S, a cardiovascular medication. This is a Firm Fixed Price Delivery Order contract with a completion date of January 8, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRHF7
    Delivery Order

This is a firm fixed price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4560512924 BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $5,272.95 and a period of performance through April 7, 2023. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside designation, suggesting open competition.

Generated 2/27/25, 11:16 AM